Differential modes of termination of amygdalothalamic and amygdalocortical projections in the monkey.
The amygdala complex participates in multiple systems having to do with affective processes. It has been implicated in human disorders of social and emotional behavior, such as autism. Of the interconnected functional networks, considerable research in rodents and primates has focused on connections between the amygdala and orbitofrontal cortex (OFC). The amygdala projects to OFC by both a direct amygdalocortical (AC) pathway and an indirect pathway through mediodorsal thalamus. In the rat, retrograde tracer experiments indicate that the AC and amygdalothalamic (AT) pathways originate from separate populations, and may therefore convey distinctive information, although the characteristics of these pathways remain unclear. To investigate this issue in monkeys we made anterograde tracer injections in the basolateral amygdala complex (BLC; n = 3). Three distinctive features were found preferentially associated with the AT or AC pathways. First, AT terminations are large (average diameter = 3.5 microm; range = 1.2-7.0 microm) and cluster around proximal dendrites, in contrast with small-bouton AC terminations. Second, AT terminations form small arbors (diameter approximately 0.1 mm), while AC are widely divergent (often >1.0 mm long). The AT terminations features are reminiscent of large bouton, "driver" corticothalamic terminations. Finally, AC but not AT terminations are positive for zinc (Zn), a neuromodulator associated with synaptic plasticity. From these results we suggest that AC and AT terminations originate from distinct populations in monkey as well as in rodent. Further work is necessary to determine the degree and manner of their segregation and how these subsystems interact within a broader connectivity network.
Miyashita
Toshio
T
Laboratory for Cortical Organization and Systematics, Brain Science Institute, RIKEN, 2-1 Hirosawa, Wako-shi, Saitama, Japan. toshio@brain.riken.jp
Ichinohe
Noritaka
N
Rockland
Kathleen S
KS
D000679:Amygdala / Q000033:anatomy & histology* / Q000378:metabolism / Q000648:ultrastructure; D000818:Animals; D001710:Biotin / Q000031:analogs & derivatives / Q000493:pharmacokinetics; D002540:Cerebral Cortex / Q000033:anatomy & histology* / Q000378:metabolism / Q000648:ultrastructure; D003911:Dextrans / Q000493:pharmacokinetics; D007150:Immunohistochemistry; D008251:Macaca / Q000033:anatomy & histology*; D046529:Microscopy, Electron, Transmission / Q000379:methods; D009434:Neural Pathways / Q000033:anatomy & histology / Q000378:metabolism / Q000648:ultrastructure; D010320:Parvalbumins / Q000378:metabolism; D017729:Presynaptic Terminals / Q000648:ultrastructure; D013788:Thalamus / Q000033:anatomy & histology* / Q000378:metabolism / Q000648:ultrastructure
D003911:Dextrans; D010320:Parvalbumins; C076397:biotinylated dextran amine; D001710:Biotin